If you have tried a few colon cancer treatments and they didn't work, or they stopped working, you may have another option: aclinical trial. Scientists look for new ways to treat stage IV colon cancer in clinical trials. These trials test new treatments to see if they are safe and if ...
Stage of presentation and prognosis of colon cancer in immigrant Chinese: Experience of a New York City Community HospitalMany inflammatory processes are self-limiting, suggesting the existence of endogenous anti-inflammatory mechanisms. Among the lipid mediators generated during cell-cell interactions are...
We have assessed the possibility to build a prognosis predictor (PP), based on non-neoplastic mucosa microarray gene expression measures, for stage II colon cancer patients. Non-neoplastic colonic mucosa mRNA samples from 24 patients (10 with a metachron
The treatment of colonic cancer presenting with intestinal obstruction. Br J Surg. 1977;64(10):741-744.PubMedGoogle ScholarCrossref 18. Sanfelippo PM, Beahrs OH. Factors in the prognosis of adenocarcinoma of the colon and rectum. Arch Surg. 1972;104(4):401-406.PubMedGoogle ScholarCross...
Current Approaches and Challenges for Monitoring Treatment Response in Colon and Rectal Cancer Introduction: With the advent of multidisciplinary and multimodality approaches to the management of colorectal cancer patients, there is an increasing nee... E Mckeown,DW Nelson,EK Johnson,... - 《Journal...
Colon cancer (CC) is the third most commonly diagnosed malignancy worldwide.1 In patients with stage III CC, oxaliplatin-based adjuvant chemotherapy (FOLFOX or CAPOX) is the current standard of care.2 However, only 30% of patients at the most will actually benefit from adjuvant treatment, leav...
The purpose of the study was to compare staging of stage II colon cancer using the number of retrieved lymph nodes (RN) to current TNM staging for stratification of prognosis.The subjects were 6307 patients with stage II colon cancer who underwent curative resection at 24 Japanese institutions. ...
The management of stage IV colorectal cancer with liver metastases has historically involved a multidisciplinary approach. In the last several decades, there have been great strides made in the therapeutic options available to treat these patients with a
The aim of this study was to evaluate the potential impact of tumor size on the long-term outcome of colon cancer (CC) patients after curative surgery. A total of 782 curatively resected T4a stage CC patients without distant metastasis were enrolled. Pat
Radical surgery followed by adjuvant chemotherapy is still the preferred curative treatment for locally advanced colon cancer; however, the prognosis remains unsatisfactory, with a 5-year overall survival (OS) rate of 52–64%2. Although distant metastasis is decreasing with the development of modern ...